Nasdaq · Healthcare
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
As-reported financials and recent SEC filings for KESTRA MEDICAL TECHNOLOGIES, LTD., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$59.8M
Net income
$-113.8M
Net margin
—
Diluted EPS
$-5.13
ROE
-55.4%
P/E (TTM)
—
Market cap
—
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2025 |
|---|---|---|
| Revenue | $59.8M | $27.8M |
| Gross profit | $24.2M | $362,000 |
| Operating income | $-106.4M | $-85.1M |
| Net income | $-113.8M | $-94.1M |
| Diluted EPS | $-5.13 | $-5.07 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-06-17
View on EDGAR →1442026-06-15
View on EDGAR →42026-06-04
View on EDGAR →42026-06-04
View on EDGAR →42026-06-04
View on EDGAR →42026-06-04
View on EDGAR →Largest Healthcare peers
Go deeper on KMTS
Search KESTRA MEDICAL TECHNOLOGIES, LTD.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.